Pancreatic Cell News Volume 14.09 | Mar 7 2023

    0
    49








    2023-03-07 | PACN 14.09


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 14.09 – 7 March, 2023
    TOP STORY

    Bioengineered Omental Transplant Site Promotes Pancreatic Islet Allografts Survival in Non-Human Primates

    Investigators explored an approach in which allogeneic islets were transplanted onto the omentum, which was bioengineered with a plasma-thrombin biodegradable matrix in three diabetic non-human primates.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract
    Tips to prepare for your next conference or networking event
    PUBLICATIONSRanked by the impact factor of the journal

    Sulfated Fuco-Manno-Glucuronogalactan Alleviates Pancreatic Beta Cell Senescence via PI3K/Akt/FoxO1 Pathway

    Sulfated fuco-manno-glucuronogalactan attenuated senescence and improved beta cell function via PI3K/Akt/FoxO1 signaling pathway.
    [International Journal of Biological Macromolecules]

    Abstract

    Methylcellulose Colony Assay and Single-Cell Micro-Manipulation Reveal Progenitor-Like Cells in Adult Human Pancreatic Ducts

    Using micro-manipulation and three-dimensional colony assays scientists identified cells within the adult human exocrine pancreas that resembled progenitor cells.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Taurine Reduces Apoptosis Mediated by Endoplasmic Reticulum Stress in Islet β-Cells Induced by High-Fat and -Glucose Diets

    The authors explored the mechanism through which taurine reduced glycolipid toxicity. INS-1 islet β-cell lines were cultured with a high concentration of fat and glucose.
    [Food and Chemical Toxicology]

    Abstract

    RRM1 Is Mediated by Histone Acetylation through Gemcitabine Resistance and Contributes to Invasiveness and ECM Remodeling in Pancreatic Cancer

    Investigators indicated that ribonucleotide reductase large subunit M1 (RRM1) expression was critical for the migratory and invasive potential of pancreatic cancer cells.
    [International Journal Of Oncology]

    Abstract

    Single-Cell and Bulk RNA Sequencing Identifies T Cell Marker Genes Score to Predict the Prognosis of Pancreatic Ductal Adenocarcinoma

    Researchers explored the predictive ability of T cell marker genes score to predict their overall survival and treatment response to immune checkpoint blockade by integrating single-cell RNA sequencing and bulk RNA-seq data, where multi-omics data of PDAC were applied.
    [Scientific Reports]

    Full Article

    Effect of STK3 on Proliferation and Apoptosis of Pancreatic Cancer Cells via PI3K/AKT/mTOR Pathway

    The authors confirmed that serine/threonine kinase 3 (STK3) has an impact on the growth, apoptosis, and metastasis of pancreatic cancer cells and investigated the related molecular mechanisms.
    [Cellular Signalling]

    Abstract

    COL11A1-Driven Positive Feedback Loop Modulates Fibroblast Transformation and Activates Pancreatic Cancer Progression

    Investigators found that PDAC-derived collagen type XI alpha 1 (COL11A1) promoted the conversion of normal fibroblasts to cancer-associated fibroblast-like cells. It included morphological and corresponding molecular marker changes.
    [Cell Biology International]

    Abstract

    Hyperthermia Reduces Irradiation-Induced Tumor Repopulation in an In Vivo Pancreatic Carcinoma Model

    The effects of joint radiotherapy/hyperthermia on optimized chick embryo chorioallantoic membrane pancreatic tumor models were investigated.
    [Advanced Biology]

    Full Article
    REVIEWS

    Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression

    The authors discuss the current understanding of PDAC metabolism by specifically exploring the metabolic dependencies of cancer stem cells (CSCs). They also review the current knowledge of targeting these metabolic factors that regulate CSC maintenance and PDAC progression.
    [Stem Cells]

    AbstractGraphical Abstract

    Signaling Pathways That Regulate Adaptive β-Cell Proliferation for the Treatment of Diabetes

    Scientists focus on signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetes considering the abovementioned issues.
    [Journal of Diabetes Investigation]

    Full Article
    INDUSTRY AND POLICY NEWS

    Panbela Announces First Patient Enrolled in South Korea for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

    Panbela Therapeutics, Inc. announced its first patient enrolled in South Korea for its ASPIRE global clinical trial in the first-line treatment of metastatic pancreatic cancer.
    [Panbela Therapeutics, Inc.]

    Press Release
    FEATURED EVENT

    Cell Culture Engineering XVIII

    April 23 – 28, 2023
    Cancun, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Fellow – Pancreatic Cancer Metastasis

    Moffitt Cancer Center – Tampa, Florida, United States

    Postdoctoral Research Fellow – Biology of Pancreatic Cancer

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Fellow – Translational Cancer Immunology & Biology

    University of Missouri – Columbia, Missouri, United States

    Faculty Position – Inflammation in Health and Disease

    University of Minnesota – Minneapolis, Minnesota, United States

    Research Faculty Position – Obstetrics and Gynecology

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter